Contraception 2002-01-01

Recent developments in contraceptive implants at the Population Council.

Irving Sivin, Alfred Moo-Young

Index: Contraception 65(1) , 113-9, (2002)

Full Text: HTML

Abstract

Development of contraceptive implant methods, when based on established or on new synthetic chemical entities, is a decadal or multi-decadal process. The process often requires the cooperation of numerous investigators for laboratory work, for early Phase II trials, for dose-finding trials, and for Phase III clinical trials. The Phase III work also requires cooperation with a commercial manufacturer and potential distributor of the product. The Population Council has recently completed developmental work on two levonorgestrel-releasing implants, with filings to regulatory agencies that support extended use of Jadelle implants for 5 years and Norplant implants for 7 years. When the developmental process includes establishing the clinical properties of a molecule not yet approved by regulatory agencies, the minimum development time appears to be two decades. The status and rationale of studies of a new Nestorone-releasing, single implant developed by the Population Council for a period of use of 2 years are presented.

Related Compounds

  • Nestoron

Related Articles:

Nestorone: clinical applications for contraception and HRT.

2003-11-01

[Steroids 68(10-13) , 907-13, (2003)]

Central modifications of allopregnanolone and beta-endorphin following subcutaneous administration of Nestorone.

2009-08-01

[J. Steroid Biochem. Mol. Biol. 116(1-2) , 15-20, (2009)]

Nestorone progestin. The ideal progestin for use in controlled release delivery systems.

1997-09-26

[Ann. N. Y. Acad. Sci. 828 , 38-46, (1997)]

Steroidal contraceptive vaginal rings.

2003-06-01

[Int. J. Clin. Pract. 57(5) , 392-5, (2003)]

Discriminant analysis of the metabolic effects of a new combined contraceptive vaginal ring containing Nestorone/EE vs. a second-generation oral contraceptive containing levonorgestrel/EE.

2012-09-01

[Contraception 86(3) , 231-7, (2012)]

More Articles...